Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO…Department of Health and Human Services$1.9M obligationsEnds Mar 31, 2028
DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26).Department of Health and Human Services$1.7M obligationsEnds Feb 29, 2028
DSC MANAGEMENT AND SUPPORT. APRIL 29, 2026 THROUGH FEBRUARY 28, 2027. N01DA-22-2253. TASK ORDER NO. 75N98026F00002 (TO 28)Department of Health and Human Services$2.4M obligationsEnds Feb 28, 2027
BETTER TOGETHER: INTEGRATING MOUD IN AFRICAN AMERICAN COMMUNITY SETTINGS. SEPTEMBER 15, 2023 TO JANUARY 31, 2026. N01DA-22-2253. TASK ORDER 75N95023F00004 (TO8).Department of Health and Human Services$1000.0K obligationsEnds Jan 31, 2027
KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).Department of Health and Human Services$2.1M obligationsEnds Mar 31, 2027
STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).Department of Health and Human Services$1.2M obligationsEnds Jan 31, 2027
DSC MANAGEMENT AND SUPPORT. APRIL 15, 2026 THROUGH NOVEMBER 30, 2027 N01DA-22-2253, TASK ORDER NO. 75N98026F00001 (TO 29) "COLLABORATIVE CARE FOR POLYSUBSTANCE USE IN PRIMARY…Department of Health and Human Services$669.9K obligationsEnds Nov 30, 2027
RURAL EXPANSION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0102). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00008 (TO24).Department of Health and Human Services$771.5K obligationsEnds May 31, 2026
DSC6 GENERAL MANAGEMENT AND SUPPORT. MARCH 1, 2026 TO APRIL 30, 2026. N01DA-22-2253. TASK ORDER NO. 75N95026F00001 (TO27). (EO) 14271: DAP-NCAP-00000077Department of Health and Human Services$345.0K obligationsEnds Apr 30, 2026
INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6…Department of Health and Human Services$2.1M obligationsEnds Sep 30, 2027
OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTATION TRIAL (CTN-013)…Department of Health and Human Services$1.9M obligationsEnds Jan 31, 2027
DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25).Department of Health and Human Services$2.3M obligationsEnds Feb 28, 2026
PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER. 12/01/2023 - 03/31/2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00001 (TO17).Department of Health and Human Services$374.9K obligationsEnds Oct 31, 2025
CRAFT. SEPTEMBER 15, 2023 - MARCH 31, 2025. N01DA-22-2253. TASK ORDER NO. 75N95023F00011 (TO15).Department of Health and Human Services$799.9K obligationsEnds Apr 28, 2025
SECONDARY ANALYSIS. SEPTEMBER 15, 2023 - SEPTEMBER 14, 2026. N01DA-22-2253. TASK ORDER NO. 75N95023F00012 (TO16)Department of Health and Human Services$754.7K obligationsEnds Apr 28, 2025
CULTURALLY CENTERED MED. ASSISTED TREATMENT OUD IMPLEMENTATION FOR PRIMARY CARE AND ADDICTION TREATMENT PROGRAMS SERVING AI/AN (CTN-0096). 03/01/2022 - 11/01/2024. DSC6…Department of Health and Human Services$499.8K obligationsEnds Mar 31, 2025
HEAL MANAGEMENT AND SUPPORT. AUGUST 2, 2024 TO AUGUST 1, 2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00005 (TO21).Department of Health and Human Services$1.3M obligationsEnds Aug 1, 2025
RTMS FOR STIMULANT USE DISORDERS (STIMULUS)(CTN-0108). 04/01/2023 - 09/01/2024. N01DA-22-2253. TASK ORDER 75N95023F00002 (TO6).Department of Health and Human Services$369.6K obligationsEnds Jan 31, 2025
RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF INJECTABLE NALTREXONE AND MONTHLY INJECTABLE BUPRENORPHINE FOR COCAINE USE DISORDER (CTN-0109). AUGUST 15, 2024 TO MARCH 31, 2026…Department of Health and Human Services$525.7K obligationsEnds Mar 31, 2026
SUBTHRESHOLD OPIOID USE DISORDER PREVENTION TRIAL (CTN-0101). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00004 (TO20).Department of Health and Human Services$113.6K obligationsEnds Mar 31, 2026
EMERGENCY DEPARTMENT-INITIATED BUPRENORPHINE AND VALIDATION NETWORK TRIAL (CTN-0099). 08/15/2023 - 10/18/2024. N01DA-22-2253. TASK ORDER 75N95023F00007 (TO11).Department of Health and Human Services$446.9K obligationsEnds May 25, 2025
EXEMPLAR HOSPITAL INITIATION TRIAL TO ENHANCE TREATMENT ENGAGEMENT (CTN-0098). JUNE 10, 2024 TO NOVEMBER 1, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00003 (TO19).Department of Health and Human Services$622.3K obligationsEnds Nov 1, 2026
DSC MANAGEMENT AND SUPPORT. FEBRUARY 29, 2024 - FEBRUARY 28, 2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00002 (TO18).Department of Health and Human Services$1.8M obligationsEnds Feb 28, 2025
POST-ANESTHESIA. SEPTEMBER 15, 2023 - SEPTEMBER 14, 2028. N01DA-22-2253. TASK ORDER 75N95023F00010 (TO14).Department of Health and Human Services$214.3K obligationsEnds Sep 14, 2028
NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2023 - 02/29/2024. N01DA-22-2253. TASK ORDER 75N95023F00003 (TO7).Department of Health and Human Services$2.2M obligationsEnds Feb 29, 2024